CTIS2023-508692-36-00招募中1 期
MedRing06
iGalli B.V.0 个研究点目标入组 12 人开始时间: 2023年10月20日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase 1 study to look at RP-6306 in combination with FOLFIRI as atreatment for Advanced Solid TumoursCTIS2024-511927-32-00Repare Therapeutics USA Inc.106
招募中
1 期
A Phase 1, open label, randomized, 2-sequence, 2-period, crossover, single center study to evaluate the pharmacokinetics of follitropin alfa from 2 manufacturing processes, administered as a single subcutaneous 450 IU dose to pituitary-suppressed healthy premenopausal female participants.InfertilityCTIS2023-507066-91-00Merck Healthcare KGaA14
招募中
1 期
Clinical study on the treatment of advanced rheumatoid arthritis (Phlegm stasis bi syndrome) by Soufeng Sanjie fomula for inhibiting bone erosioRheumatoid arthritisITMCTR2200006853Jiangsu Integrated Traditional Chinese and Western Medicine Hospital
进行中（未招募）
1 期
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy ParticipantsCTIS2024-512841-17-00Merck Healthcare KGaA40
招募中
1 期
A Phase 2 Proof of Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of OMS906 in PNH Patients with a Sub-optimal Response to the C5 inhibitor, RavulizumabCTIS2022-501190-39-01Omeros Ireland Limited14